[1]张飞扬 陈 刚.中外新型冠状病毒感染的肺炎诊疗指南之异同[J].福建医药杂志,2020,42(02):12-15.
点击复制

中外新型冠状病毒感染的肺炎诊疗指南之异同()
分享到:

《福建医药杂志》[ISSN:1002-2600/CN:35-1071/R]

卷:
42
期数:
2020年02期
页码:
12-15
栏目:
专题报告
出版日期:
2020-04-15

文章信息/Info

文章编号:
1002-2600(2020)02-0012-04
作者:
张飞扬 陈 刚12
福建医科大学(福州 350001)
关键词:
新型冠状病毒 肺炎 诊疗指南
分类号:
R563.1
文献标志码:
A

参考文献/References:

[1] 国家卫生健康委办公厅, 国家中医药管理局办公室. 关于印发新型冠状病毒感染的肺炎诊疗方案(试行第五版)的通知[EB/OL]. 医政医管局,(2020-02-05)[2020-02-05]. http://www.nhc.gov.cn/xcs/zhengcwj/202002/3b09b894ac9b4204-a79db5b8912d4440.shtml.
[2] CDC. Interim Clinical Guidance for Management of Patients with Confirmed 2019 Novel Coronavirus(2019-nCoV)Infection [EB/OL]. Centers for Disease Control and Prevention,(2020-01-30)[2020-02-04]. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html.
[3] Government of UK. Guidance Coronavirus:latest information and advice [EB/OL]. Government of United Kingdom,(2020-02-03)[2020-02-04]. https://www.gov.uk/guidance/wuhan-novel-coronavirus-information-for-the-public.
[4] Australian Government Department of Health. Novel corona-virus(2019-nCoV)[EB/OL]. Australian Government,(2020-02-02)[2020-02-04]. https://www.health.gov.au/health-topics/novel-coronavirus-2019-ncov.
[5] Government of Canada. 2019 novel coronavirus: For health professionals [EB/OL]. Government of Canada,(2020-02-03)[2020-02-04]. https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/health-professionals.html.
[6] Singapore Ministry of Health. Updates on 2019 novel corona-virus(2019-NCOV)local situation[EB/OL]. Government of Singapore,(2020-02-04)[2020-02-04]. https://www.moh.gov.sg/2019-ncov-wuhan.
[7] Al-Abdely H M, Midgley C M, Alkhamis A M, et al. Middle East respiratory syndrome coronavirus infection dynamics and antibody responses among clinically diverse patients, Saudi Arabia[J]. Emerging Infectious Diseases, 2019, 25(4): 753.
[8] Corman V M, Albarrak A M, Omrani A S, et al. Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection[J]. Clinical Infectious Diseases, 2016, 62(4): 477-483.
[9] Arabi Y M, Mandourah Y, Al-Hameed F, et al. Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome[J]. American journal of respiratory and critical care medicine, 2018, 197(6): 757-767.
[10] Chan J F-W, Yuan S, Kok K-H, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster[J]. The Lancet, 2020, 395(10223): 514-523.
[11] Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019[J]. The New England journal of medicine, 2020, 382(8): 727-733.
[12] Brown A J, Won J J, Graham R L, et al. Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase[J]. Antiviral research, 2019, 169: 104541.
[13] Sheahan T P, Sims A C, Leist S R, et al. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV[J]. Nature Communications, 2020, 11(1): 1-14.
[14] Sheahan T P, Sims A C, Graham R L, et al. Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses[J]. Science translational medicine, 2017, 9(396):3653.

相似文献/References:

[1]郑泽宇 综述 陈 刚 审校.2019-nCoV肺炎的研究现状与未来展望[J].福建医药杂志,2020,42(01):1.
 ZHENG Zeyu,CHEN Gang..Research status and future prospect of 2019-nCoV pneumonia[J].FUJIAN MEDICAL JOURNAL,2020,42(02):1.
[2]陈宏毅 卓秀明.需机械通气的重症肺炎患者应用纤支镜治疗的效果分析[J].福建医药杂志,2020,42(05):63.
[3]刘歆,林金霞,江发英,等.老年鹦鹉热衣原体肺炎3例临床分析[J].福建医药杂志,2023,45(03):15.
 LIU Xin,LIN Jinxia,JIANG Faying,et al.Clinical features of Chlamydia psittaci pneumonia in the elderly[J].FUJIAN MEDICAL JOURNAL,2023,45(02):15.
[4]朱 峥 综述 陈 刚 审校.新型冠状病毒肺炎临床研究前后对比及特殊人群临床特点[J].福建医药杂志,2020,42(02):7.

备注/Memo

备注/Memo:
1 福建省医科大学省立临床医学院,福建省医学科学研究院,福建省医学测试重点实验室2 通信作者,Email:chengangfj@163.com
更新日期/Last Update: 2020-04-15